Hilco Industrial Acquisitions, an Amsterdam-based Industrial Asset Disposition and Acquisition Company, acquired all Machinery & Equipment from the Swiss-based CMO Legacy Pharmaceuticals. The Cantonal Insolvency Department Basel-Land organised a liquidation sale of all assets at the end of March 2021. Hilco is awarded the acquisition of all Machinery & Equipment.
Legacy Pharmaceutical Packaging has purchased a 215,000-square-foot open-space facility to introduce comprehensive, wide-scale 3PL and distribution services. Located near the company’s headquarters in the St. Louis, MO area, the building will extend Legacy’s servicing capabilities for OTC and Rx pharma customers well past its historic CPO roots, and bring the company’s total footprint to more than 500,000 sq.-ft.
Legacy Pharmaceuticals Switzerland GmbH Fails EDQM Inspection
Legacy Pharmaceuticals announced that preparations to meet the new Russian track and trace regulation, Federal Law No. 425-FZ, are well advanced. Due to be introduced in January 2020, the regulation sets a new bar for serialization, compliance reporting, and data management. Regulation sets new bar for serialization, compliance reporting, and data management
Legacy Pharmaceuticals, a global contract manufacturer of sterile/aseptic pharmaceutical products in ampoules and vials, has unveiled their long-term expansion strategy to address the global growth in demand for lyophilization in vials. The 5-year plan builds on Legacy’s existing core fill-finish competencies in lyophilization, and liquid and powder vials. As a first step Legacy has already started a project to add customized lyophilization in vials for an ongoing customer project, with an anticipated start date of mid-2020